Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 4
1965 2
1966 3
1967 3
1968 5
1969 2
1970 3
1971 1
1973 2
1974 3
1975 1
1976 2
1977 3
1978 3
1979 3
1980 11
1981 8
1982 16
1983 9
1984 17
1985 18
1986 18
1987 23
1988 30
1989 22
1990 17
1991 20
1992 13
1993 17
1994 16
1995 12
1996 18
1997 23
1998 18
1999 23
2000 23
2001 29
2002 31
2003 28
2004 24
2005 28
2006 28
2007 31
2008 24
2009 28
2010 16
2011 21
2012 15
2013 16
2014 16
2015 13
2016 9
2017 13
2018 9
2019 5
2020 14
2021 12
Text availability
Article attribute
Article type
Publication date

Search Results

792 results
Results by year
Filters applied: . Clear all
Page 1
Cancer immunotherapies targeting the PD-1 signaling pathway.
Iwai Y, Hamanishi J, Chamoto K, Honjo T. Iwai Y, et al. Among authors: honjo t. J Biomed Sci. 2017 Apr 4;24(1):26. doi: 10.1186/s12929-017-0329-9. J Biomed Sci. 2017. PMID: 28376884 Free PMC article. Review.
Role of PD-1 in Immunity and Diseases.
Chamoto K, Al-Habsi M, Honjo T. Chamoto K, et al. Among authors: honjo t. Curr Top Microbiol Immunol. 2017;410:75-97. doi: 10.1007/82_2017_67. Curr Top Microbiol Immunol. 2017. PMID: 28929192 Review.
PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ. Latchman Y, et al. Among authors: honjo t. Nat Immunol. 2001 Mar;2(3):261-8. doi: 10.1038/85330. Nat Immunol. 2001. PMID: 11224527
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I. Hamanishi J, et al. Among authors: honjo t. J Clin Oncol. 2015 Dec 1;33(34):4015-22. doi: 10.1200/JCO.2015.62.3397. Epub 2015 Sep 8. J Clin Oncol. 2015. PMID: 26351349 Clinical Trial.
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy.
Hatae R, Chamoto K, Kim YH, Sonomura K, Taneishi K, Kawaguchi S, Yoshida H, Ozasa H, Sakamori Y, Akrami M, Fagarasan S, Masuda I, Okuno Y, Matsuda F, Hirai T, Honjo T. Hatae R, et al. Among authors: honjo t. JCI Insight. 2020 Jan 30;5(2):e133501. doi: 10.1172/jci.insight.133501. JCI Insight. 2020. PMID: 31855576 Free PMC article.
792 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page